A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Mapping Genome-wide Accessible Chromatin in Primary Human T Lymphocytes by ATAC-Seq

17.8K views

⸱

DOI:

10.3791/56313

⸱

November 13th, 2017

 ,  ,  ,  , 

In This Article

Summary

Assay for Transposase-Accessible Chromatin coupled with high-throughput sequencing (ATAC-seq) is a genome-wide method to uncover accessible chromatin. This is a step-by-step ATAC-seq protocol, from molecular to the final computational analysis, optimized for human lymphocytes (Th1/Th2). This protocol can be adopted by researchers without prior experience in next-generation sequencing methods.

Abstract

Assay for Transposase-Accessible Chromatin with high-throughput sequencing (ATAC-seq) is a method used for the identification of open (accessible) regions of chromatin. These regions represent regulatory DNA elements (e.g., promoters, enhancers, locus control regions, insulators) to which transcription factors bind. Mapping the accessible chromatin landscape is a powerful approach for uncovering active regulatory elements across the genome. This information serves as an unbiased approach for discovering the network of relevant transcription factors and mechanisms of chromatin structure that govern gene expression programs. ATAC-seq is a robust and sensitive alternative to DNase I hypersensitivity analysis coupled with next-generation sequencing (DNase-seq) and formaldehyde-assisted isolation of regulatory elements (FAIRE-seq) for genome-wide analysis of chromatin accessibility and to the sequencing of micrococcal nuclease-sensitive sites (MNase-seq) to determine nucleosome positioning. We present a detailed ATAC-seq protocol optimized for human primary immune cells i.e. CD4+ lymphocytes (T helper 1 (Th1) and Th2 cells). This comprehensive protocol begins with cell harvest, then describes the molecular procedure of chromatin tagmentation, sample preparation for next-generation sequencing, and also includes methods and considerations for the computational analyses used to interpret the results. Moreover, to save time and money, we introduced quality control measures to assess the ATAC-seq library prior to sequencing. Importantly, the principles presented in this protocol allow its adaptation to other human immune and non-immune primary cells and cell lines. These guidelines will also be useful for laboratories which are not proficient with next-generation sequencing methods.

Introduction

ATAC-seq1,2 is a robust method that enables identification of regulatory3 open chromatin regions and nucleosome positioning. This information is applied for inferring the location, identity, and activity of transcription factors. The method's sensitivity for measuring quantitative variations in chromatin structure allows the study of the activity of chromatin factors, including chromatin remodelers and modifiers, as well as the transcriptional activity of RNA polymerase II1. Thus ATAC-seq provides a powerful and unbiased approach for deciphering mechanisms th....

Access restricted. Please log in or start a trial to view this content.

Protocol

All the procedures were approved by institutional review board of Bar Ilan University and the protocol follows guidelines provided by the committee approving the experiments.

1. Purification of Naïve Human CD4+ Cells and Polarization to T Helper 1 (Th1) and Th2 Cells

Note: Here we describe the procedure starting from frozen human peripheral blood mononuclear cells (PBMCs). The first step consists of isolating CD4+ cells using microbeads and columns that usually give us more than 95% of CD4+ cells. However, this step may vary according to the preferred protocol in each lab. The protocol for T cell activation an....

Access restricted. Please log in or start a trial to view this content.

Results

The final outcome of this protocol is an ATAC-seq library of typically 3 - 20 ng/µL. When run on a system for DNA integrity analysis (see Table of Materials/Equipment), they show ladder-like appearance2 (Figure 3A). The average size of DNA fragments is typically ~450 - 530 bp.

Proper quality control of the ATAC-seq libraries prior to performing next-generatio.......

Access restricted. Please log in or start a trial to view this content.

Discussion

The ATAC-seq protocol described here has been successfully employed for the analysis of accessible chromatin in primary cells (human Th1, Th2 cells, and B cells) as well as the cultured cell lines (MCF10A human breast cancer cells and U261 glioblastoma cells). Applying ATAC-seq to other cell types may require some protocol optimization, especially in the lysis step. If the concentration of non-ionic detergent is too high, there may be a higher percentage of mitochondrial DNA contamination. This can be reduced by decreasi.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work is supported by the Israel Science Foundation (grant 748/14), Marie Curie Integration grant (CIG)- FP7-PEOPLE-20013-CIG-618763 and I-CORE Program of the Planning and Budgeting Committee and The Israel Science Foundation grant no. 41/11.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
50 mL tubesLumitronLUM-CFT011500-PCan be from other vendors.
MicrotubesAxygen IncMCT-175-CCan be from other vendors.
25 mL serological pipettesCorning Costar4489Can be from other vendors.
Tissue culture flaskLumitronLUM-TCF-012-250-PCan be from other vendors.
Countes Automated Cell CounterInvitrogenC10227
NucleoSpin TissueMACHEREY-NAGEL740952.5
Peripheral blood mononuclear cells (PBMC)ATCC PCS­800­011Can be from other vendors.
RPMI 1640 MediumBiological Industries01-103-1ACan be from other vendors.
L-Glutamine Solution (200 mM)Biological Industries03-020-1BCan be from other vendors.
Penicillin-StreptomycinBiological Industries03-031-1BCan be from other vendors.
Fetal Bovine Serum (FBS), Heat Inactivated, European GradeBiological Industries04-127-1Can be from other vendors.
MACS CD4 microbeads, humanMiltenyi Biotec130-045-101
MACS MS columnsMiltenyi Biotec130-042-201
Anti-Human CD4 FITCBiogems06121-50
Mouse IgG1 Isotype Control FITCBiogems44212-50
Anti-Human CD3 (OKT3)Tonbo biosciences40-0037
Anti-Human CD28 SAFIRE PurifiedBiogems10311-25
Recombinant Human IL2Peprotech200-02
Recombinant Human IL4Peprotech200-04
Recombinant Human IL12 p70Peprotech200-12
In Vivo Ready Anti-Human IL-4 (MP4-25D2)Tonbo40-7048
LEAF Purified anti-human IFN-γBioLegend506513
NaCl, analytical gradeCarlo Erba479687Can be from other vendors.
Magnesium chloride, Hexahydrate, molecular biology gradeCalbiochem442611Can be from other vendors.
EDTAMP Biomedicals800682Can be from other vendors.
Tris, ultra pure, 99.9% pureMP Biomedicals819620Can be from other vendors.
NP-40 alternative (Nonylphenyl Polyethylene Glycol)Calbiochem492016Can be from other vendors.
Protease InhibitorsSigmaP2714this protease inhibitor coctail is a powder. To make 100 x solution dilute in 1 mL of molecular-biology grade water.
Magnetic solid phase reverse immobilization beads: AMPure XP beadsBeckman63881
PCR purification kitHyLabsEX-GP200Can be from other vendors.
Nextera DNA Library Preparation Kit (TDE1 transposase and TD buffer)IlluminaFC-121-1030
NEBNext High-Fidelity 2 x PCR Master MixNew England BioLabsM0541
NEBNext Q5 Hot Start HiFi PCR Master MixNew England BioLabsM0543
SYBR Green I InvitrogenS7585
 CFX Connect Real-Time PCR Detection SystemBio-rad185-5200Can be from other vendors.
CFX Manager SoftwareBio-rad1845000
master mix for qPCR: iTaq Universal SYBR Green SupermixBio-rad172-5124Can be from other vendors.
Qubit fluorometer 2.0InvitrogenQ32866
Qubit dsDNA HS Assay KitInvitrogenQ32854
Magnet for eppendorf tubesInvitrogen12321DCan be from other vendors.
Swing bucket cooling centrifuge with the buckets for 15 mL falcon tubes and eppendorf tubesThermo Scientific75004527Could be from other vendors. It is important that it has buckets for eppendorf tubes.
Thermo-shakerMRCCan be from other vendors.
High Sensitivity D1000 ScreenTapeAgilent Technologies5067-5584
High Sensitivity D1000 ReagentsAgilent Technologies5067-5585
4200 TapeStation systemAgilent TechnologiesG2991AATape-based platform for  electrophoresis
High Sensitivity DNA kitAgilent Technologies5067-4626Reagent for high-sensitivity TapeStation analysis
Primer name and sequenceCompany
Ad1_noMX: 5'-AATGATACGGCGACCACCGAGA
TCTACACTCGTCGGCAGCGTC
AGATGTG-3'
IDTAd1-noMx: 5'-P5 sequence-transposase sequence-3'
Ad2.1_TAAGGCGA: 5'-CAAGCAGAAGACGGCATACGAG
AT[TCGCCTTA]GTCTCGTGGGC
TCGGAGATGT-3'
IDTAd2.1_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
Ad2.2_CGTACTAG: 5'-CAAGCAGAAGACGGCATACGAG
AT[CTAGTACG]GTCTCGTGGGC
TCGGAGATGT-3'
IDTAd2.2_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
Ad2.3_AGGCAGAA: 5'-CAAGCAGAAGACGGCATACGA
GAT[TTCTGCCT]GTCTCGTGGGC
TCGGAGATGT-3'
IDTAd2.3_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
Ad2.4_TCCTGAGC: 5'-CAAGCAGAAGACGGCATACGAG
AT[GCTCAGGA]GTCTCGTGGGC
TCGGAGATGT-3'
IDTAd2.4_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
Ad2.5_GGACTCCT: 5'-CAAGCAGAAGACGGCATACGA
GAT[AGGAGTCC]GTCTCGTGGG
CTCGGAGATGT-3'
IDTAd2.5_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
Ad2.6_TAGGCATG: 5'-CAAGCAGAAGACGGCATACGA
GAT[CATGCCTA]GTCTCGTGGGC
TCGGAGATGT-3'
IDTAd2.6_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
Ad2.7_CTCTCTAC: 5'-CAAGCAGAAGACGGCATACGA
GAT[GTAGAGAG]GTCTCGTGGG
CTCGGAGATGT-3'
IDTAd2.7_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
Ad2.8_CAGAGAGG: 5'-CAAGCAGAAGACGGCATACGA
GAT[CCTCTCTG]GTCTCGTGGGC
TCGGAGATGT-3'
IDTAd2.8_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
Ad2.9_GCTACGCT: 5'-CAAGCAGAAGACGGCATACGA
GAT[AGCGTAGC]GTCTCGTGGGC
TCGGAGATGT-3'
IDTAd2.9_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
Ad2.10_CGAGGCTG: 5'-CAAGCAGAAGACGGCATACG
AGAT[CAGCCTCG]GTCTCGTGG
GCTCGGAGATGT-3'
IDTAd2.10_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
Ad2.11_AAGAGGCA: 5'-CAAGCAGAAGACGGCATACG
AGAT[TGCCTCTT]GTCTCGTGGG
CTCGGAGATGT-3'
IDTAd2.11_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
Ad2.12_GTAGAGGA: 5'-CAAGCAGAAGACGGCATACG
AGAT[TCCTCTAC]GTCTCGTGGG
CTCGGAGATGT-3'
IDTAd2.12_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
Ad2.13_GTCGTGAT: 5'-CAAGCAGAAGACGGCATACGA
GAT[ATCACGAC]GTCTCGTGGGC
TCGGAGATGT-3'
IDTAd2.13_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
Ad2.14_ACCACTGT: 5'- CAAGCAGAAGACGGCATACGA
GAT[ACAGTGGT]GTCTCGTGGGC
TCGGAGATGT-3'
IDTAd2.14_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
Ad2.15_TGGATCTG: 5'- CAAGCAGAAGACGGCATACGA
GAT[CAGATCCA]GTCTCGTGGGC
TCGGAGATGT-3'
IDTAd2.15_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
Ad2.16_CCGTTTGT: 5'- CAAGCAGAAGACGGCATACGA
GAT[ACAAACGG]GTCTCGTGGGC
TCGGAGATGT-3'
IDTAd2.16_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
 Ad2.17_TGCTGGGT: 5'- CAAGCAGAAGACGGCATACGA
GAT[ACCCAGCA]GTCTCGTGGGC
TCGGAGATGT-3'
IDTAd2.17_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
 Ad2.18_GAGGGGTT: 5'-CAAGCAGAAGACGGCATACGA
GAT[AACCCCTC]GTCTCGTGGGC
TCGGAGATGT-3'
IDTAd2.18_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
Ad2.19_AGGTTGGG: 5'-CAAGCAGAAGACGGCATACGA
GAT[CCCAACCT]GTCTCGTGGGC
TCGGAGATGT-3'
IDTAd2.19_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
 Ad2.20_GTGTGGTG: 5'-CAAGCAGAAGACGGCATACGA
GAT[CACCACAC]GTCTCGTGGGC
TCGGAGATGT-3'
IDTAd2.20_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
 Ad2.21_TGGGTTTC: 5'-CAAGCAGAAGACGGCATACGA
GAT[GAAACCCA]GTCTCGTGGGC
TCGGAGATGT-3'
IDTAd2.21_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
Ad2.22_TGGTCACA: 5'- CAAGCAGAAGACGGCATACGA
GAT[TGTGACCA]GTCTCGTGGGC
TCGGAGATGT-3'
IDTAd2.22_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
Ad2.23_TTGACCCT: 5'-CAAGCAGAAGACGGCATACGA
GAT[AGGGTCAA]GTCTCGTGGGC
TCGGAGATGT-3'
IDTAd2.23_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
Ad2.24_CCACTCCT: 5'-CAAGCAGAAGACGGCATACGA
GAT[AGGAGTGG]GTCTCGTGGG
CTCGGAGATGT-3'
IDTAd2.24_expected index sequence read: 5'-P7 sequence-[index sequence]-transposase sequence-3'
F1: 5'-CCTTTTTATTTGCCCATACACTC-3'IDT
R1: 5'-CCCAGATAGAAAGTTGGAGAGG-3'IDT
F2: 5'-TTGAGGGATGCCATAACAGTC-3'IDT
R2: 5'-CTGCTGAACAACATCCTTCAC-3'IDT
F3: 5'-GGTTTGCAGGTTGCGTTG-3'IDT
R3: 5'-AGAGGAATCTGGGAGTGACG-3'IDT
F4: 5'-TGCTCATTCCGTTTCCCTAC-3'IDT
R4: 5'-AGCCGGAAAGAAAGTTCCTG-3'IDT

References

  1. Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y., Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods. 10 (12), 1213-1218 (2013).
  2. Buenrostro, J. D., Wu, B., Chang, H. Y., Greenleaf, W. J.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Chromatin AccessibilityPrimary T LymphocytesNuclei IsolationTransposition ReactionLibrary AmplificationQuality Control MeasuresPeak Calling AnalysisDNA Cleanup StepMagnetic Bead Purification